Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00791349 | A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone | PHASE1 | COMPLETED | 141 | — | — | Feb 1, 2005 | May 1, 2005 | Jun 8, 2011 | - | — |
| Name | Type | Description |
|---|---|---|
| Immediate release (IR) Paliperidone | DRUG | - |
Inclusion Criteria: * Patients must have a diagnosis of schizophrenia or schizoaffective disorder as defined by DSM-IV criteria, with no exacerbation of psychosis for at least 3 months prior to screening * Patients must have a normal 12-lead ECG at screening and on Day -1, including: Normal sinus r...